Table 4.
Univariate analysis of characteristics, comorbidities, and laboratory data between patients with recovered and worsened respiratory condition
| All (n = 300) | Recovered (n = 276) | Worsened (n = 21) | P value | |
|---|---|---|---|---|
| Age (year) | 53 (33–72) | 52 (32–72) | 63 (48–73) | 0.03 |
| Sex (male) | 171 (57%) | 150 (54%) | 20 (95%) | < 0.001 |
| Body mass index (kg/m2) | 23 (21–26) | 23 (21–26) | 25 (24–26) | 0.04 |
| Comorbidities | ||||
| Hypertension | 68 (23%) | 62 (21%) | 6 (29%) | 0.3 |
| Diabetes mellitus | 60 (20%) | 50 (18%) | 10 (48%) | 0.003 |
| Laboratory data | ||||
| White blood cell count (×109/L) | 5.2 (4.0–7.0) | 5.2 (4.0–6.9) | 5.4 (5.0–6.7) | 0.5 |
| Lymphocyte (× 109/L) | 1.2 (0.9 − 1.6) | 1.2 (0.9 − 1.6) | 1.0 (0.7 − 1.4) | 0.04 |
| Aspartate aminotransferase (U/L) | 27 (20–39) | 27 (20–37) | 36 (31–54) | < 0.001 |
| Alanine aminotransferase (U/L) | 24 (14–41) | 22 (13–40) | 34 (27–57) | 0.003 |
| Lactate dehydrogenase (U/L) | 212 (173–272) | 209 (168–265) | 267 (221–348) | < 0.001 |
| Creatinine (mg/dL) | 0.76 (0.61–1.00) | 0.76 (0.61–0.91) | 0.83 (0.75–0.95) | 0.03 |
| C-reactive protein (mg/dL) | 1.8 (0.4–4.5) | 1.5 (0.3–4.0) | 5.2 (3.5–9.2) | < 0.001 |
| Fibrinogen (mg/dL) | 420 (327–548) | 411 (322–531) | 548 (470–635) | < 0.001 |
| D-dimer (µg/dL) | 0.9 (0.7–1.4) | 0.9 (0.7–1.4) | 1.0 (0.9–1.6) | 0.16 |
| Ferritin (ng/mL) | 397 (189–800) | 362 (166–733) | 1006 (530–1409) | < 0.001 |
Data are expressed as the absolute value (percentage) or median (25–75% interquartile range)